191 related articles for article (PubMed ID: 38674001)
1. The
Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732
[TBL] [Abstract][Full Text] [Related]
4. OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells.
Kaur R; Aiken C; Morrison LC; Rao R; Del Bigio MR; Rampalli S; Werbowetski-Ogilvie T
Dis Model Mech; 2015 Oct; 8(10):1295-309. PubMed ID: 26398939
[TBL] [Abstract][Full Text] [Related]
5. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.
Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y
PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066
[TBL] [Abstract][Full Text] [Related]
6. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M
J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029
[TBL] [Abstract][Full Text] [Related]
7. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.
Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN
Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356
[TBL] [Abstract][Full Text] [Related]
8. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.
Adamson DC; Shi Q; Wortham M; Northcott PA; Di C; Duncan CG; Li J; McLendon RE; Bigner DD; Taylor MD; Yan H
Cancer Res; 2010 Jan; 70(1):181-91. PubMed ID: 20028867
[TBL] [Abstract][Full Text] [Related]
9. OTX1 and OTX2 Genes in Medulloblastoma.
Figueira Muoio VM; Uno M; Oba-Shinjo S; da Silva R; Araújo Pereira BJ; Clara C; Matushita H; Marie SNK
World Neurosurg; 2019 Jul; 127():e58-e64. PubMed ID: 30797919
[TBL] [Abstract][Full Text] [Related]
10. An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.
Zagozewski J; Shahriary GM; Morrison LC; Saulnier O; Stromecki M; Fresnoza A; Palidwor G; Porter CJ; Forget A; Ayrault O; Hawkins C; Chan JA; Vladoiu MC; Sundaresan L; Arsenio J; Taylor MD; Ramaswamy V; Werbowetski-Ogilvie TE
Nat Commun; 2020 Jul; 11(1):3627. PubMed ID: 32686664
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
12. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.
Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M
Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830
[TBL] [Abstract][Full Text] [Related]
13. Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.
Bunt J; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
PLoS One; 2011; 6(10):e26058. PubMed ID: 22016811
[TBL] [Abstract][Full Text] [Related]
14. Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma.
Jenkins NC; Kalra RR; Dubuc A; Sivakumar W; Pedone CA; Wu X; Taylor MD; Fults DW
Acta Neuropathol Commun; 2014 Jul; 2():85. PubMed ID: 25059231
[TBL] [Abstract][Full Text] [Related]
15. Modeling medulloblastoma in vivo and with human cerebellar organoids.
Ballabio C; Anderle M; Gianesello M; Lago C; Miele E; Cardano M; Aiello G; Piazza S; Caron D; Gianno F; Ciolfi A; Pedace L; Mastronuzzi A; Tartaglia M; Locatelli F; Ferretti E; Giangaspero F; Tiberi L
Nat Commun; 2020 Jan; 11(1):583. PubMed ID: 31996670
[TBL] [Abstract][Full Text] [Related]
16. OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.
Bai RY; Staedtke V; Lidov HG; Eberhart CG; Riggins GJ
Cancer Res; 2012 Nov; 72(22):5988-6001. PubMed ID: 22986744
[TBL] [Abstract][Full Text] [Related]
17. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.
Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC
Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460
[TBL] [Abstract][Full Text] [Related]
18. miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164.
Shi JA; Lu DL; Huang X; Tan W
Int J Mol Med; 2014 Jul; 34(1):237-43. PubMed ID: 24756834
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.
Bai AH; Milde T; Remke M; Rolli CG; Hielscher T; Cho YJ; Kool M; Northcott PA; Jugold M; Bazhin AV; Eichmüller SB; Kulozik AE; Pscherer A; Benner A; Taylor MD; Pomeroy SL; Kemkemer R; Witt O; Korshunov A; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):529-38. PubMed ID: 22134538
[TBL] [Abstract][Full Text] [Related]
20. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
